The Toxoplasma gondii F-Box Protein L2 Functions as a Repressor of Stage Specific Gene Expression.


Journal

PLoS pathogens
ISSN: 1553-7374
Titre abrégé: PLoS Pathog
Pays: United States
ID NLM: 101238921

Informations de publication

Date de publication:
30 May 2024
Historique:
received: 18 12 2023
accepted: 17 05 2024
medline: 30 5 2024
pubmed: 30 5 2024
entrez: 30 5 2024
Statut: aheadofprint

Résumé

Toxoplasma gondii is a foodborne pathogen that can cause severe and life-threatening infections in fetuses and immunocompromised patients. Felids are its only definitive hosts, and a wide range of animals, including humans, serve as intermediate hosts. When the transmissible bradyzoite stage is orally ingested by felids, they transform into merozoites that expand asexually, ultimately generating millions of gametes for the parasite sexual cycle. However, bradyzoites in intermediate hosts differentiate exclusively to disease-causing tachyzoites, which rapidly disseminate throughout the host. Though tachyzoites are well-studied, the molecular mechanisms governing transitioning between developmental stages are poorly understood. Each parasite stage can be distinguished by a characteristic transcriptional signature, with one signature being repressed during the other stages. Switching between stages require substantial changes in the proteome, which is achieved in part by ubiquitination. F-box proteins mediate protein poly-ubiquitination by recruiting substrates to SKP1, Cullin-1, F-Box protein E3 ubiquitin ligase (SCF-E3) complexes. We have identified an F-box protein named Toxoplasma gondii F-Box Protein L2 (TgFBXL2), which localizes to distinct perinucleolar sites. TgFBXL2 is stably engaged in an SCF-E3 complex that is surprisingly also associated with a COP9 signalosome complex that negatively regulates SCF-E3 function. At the cellular level, TgFBXL2-depleted parasites are severely defective in centrosome replication and daughter cell development. Most remarkable, RNAseq data show that TgFBXL2 conditional depletion induces the expression of stage-specific genes including a a large cohort of genes necessary for sexual commitment. Together, these data suggest that TgFBXL2 is a latent guardian of stage specific gene expression in Toxoplasma and poised to remove conflicting proteins in response to an unknown trigger of development.

Identifiants

pubmed: 38814984
doi: 10.1371/journal.ppat.1012269
pii: PPATHOGENS-D-23-02238
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e1012269

Informations de copyright

Copyright: © 2024 Baptista et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Auteurs

Carlos G Baptista (CG)

Department of Microbiology and Immunology, University at Buffalo School of Medicine, Buffalo, New York, United States of America.

Sarah Hosking (S)

Department of Microbiology and Immunology, University at Buffalo School of Medicine, Buffalo, New York, United States of America.

Elisabet Gas-Pascual (E)

Department of Biochemistry & Molecular Biology, Center for Tropical & Emerging Global Diseases, University of Georgia, Athens, Georgia United States of America.

Loic Ciampossine (L)

Department of Molecular, Cell, and Systems Biology, University of California Riverside, Riverside, California, United States of America.

Steven Abel (S)

Department of Molecular, Cell, and Systems Biology, University of California Riverside, Riverside, California, United States of America.

Mohamed-Ali Hakimi (MA)

Host-Pathogen Interactions and Immunity to Infection, Institute for Advanced Biosciences (IAB), INSERM U1209, CNRS UMR 5309, Grenoble Alpes University, Grenoble, France.

Victoria Jeffers (V)

Department of Molecular, Cellular and Biomedical Sciences, University of New Hampshire, Durham, New Hampshire, United States of America.

Karine Le Roch (K)

Department of Molecular, Cell, and Systems Biology, University of California Riverside, Riverside, California, United States of America.

Christopher M West (CM)

Department of Biochemistry & Molecular Biology, Center for Tropical & Emerging Global Diseases, University of Georgia, Athens, Georgia United States of America.

Ira J Blader (IJ)

Department of Microbiology and Immunology, University at Buffalo School of Medicine, Buffalo, New York, United States of America.

Classifications MeSH